Cholestatic liver disease in an adolescent: don't forget progressive familial intrahepatic Cholestasis-8.

Research progress on the role of gut microbiota dysbiosis in the pathogenesis of immune-mediated liver diseases.

Dysbiotic microbiota trigger colitis-associated colorectal cancer and imprint a distinctive bile acid profile in a PSC-IBD model.

Primary sclerosing cholangitis.

Microscopic colitis and primary sclerosing cholangitis are bidirectionally associated: A nationwide matched cohort and case-control study.

Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease.

Beyond alkaline phopshatase: can anti-integrin αvβ6 autoantibodies serve as biomarkers in primary sclerosing cholangitis trials?

Conjugated bile acids facilitate cholangiocyte senescence to promote cholestatic liver diseases via STING signaling.

Colitis-Associated Carcinoma: The Quintessential Epithelial Neoplasia Driven by Chronic Inflammation.

Mast Cells at the Crossroad of Gut-Derived Signals Through Aryl Hydrocarbon Receptor Activation: A Microbial-Immune Dialogue in Liver Inflammation with Therapeutic Perspectives.

Prevalence of Comorbidities in Inflammatory Bowel Disease: An Umbrella Review of 18 Systematic Reviews.

Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantation.

Prevalence, interreader agreement, and prognostic value of high-grade and relevant strictures in individuals with primary sclerosing cholangitis.

Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report.

Defining the Contribution of Genetic Variants in MRGPRX4 With Pruritus in Paediatric Cholestasis: Evidence From Case-Control Study.

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.

Constructing a protein-protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses.

Fatigue and circadian rhythm in non-cirrhotic primary biliary cholangitis: An exploratory comparison with primary sclerosing cholangitis and healthy controls.

The role and possible mechanism of intestinal fungi in the progression of chronic liver diseases.

Duct-to-Duct Versus Roux-en-Y in Liver Transplantation for Primary Sclerosing Cholangitis: When Evidence Leaves Room for Pragmatism.

[A new paradigm of the pathogenesis of primary sclerosing cholangitis associated with ulcerative colitis: microbiota and system intestine-liver. A review].

Recurrent ileocolic variceal hemorrhage treated with superselective Onyx embolization: A case report.

Primary sclerosing cholangitis pathogenesis revisited: EBV-idence of immune dysregulation.

Clinico-pathological and immunohistochemical profile of plasma cell rich variants of chronic cholecystitis.

Cardiovascular risk profiles in patients with primary sclerosing cholangitis.

Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis.

Prognostic value of magnetic resonance imaging in pediatric-onset primary sclerosing cholangitis.

Bile Acid Sequestrants in Primary Sclerosing Cholangitis and the Risk of Acute Cholangitis: Cause for Concern?

Acquired bisalbuminemia associated with hepatobiliary disease: a two-case report and diagnostic implications.

Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC.

Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations.

IgG4-related sclerosing cholangitis: navigating diagnostic dilemmas and the challenge of relapse.

Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.

Statistics and epidemiology of inflammatory bowel disease-associated colorectal neoplasia.

Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward.

The Utility of Elastography in Discriminating Stages of Liver Fibrosis and Risk Stratification in Patients With Primary Sclerosing Cholangitis: A Systematic Review.

Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.

Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and Progression.

A Mendelian randomization study exploring the genetic associations between biliary system disorders and brain structural changes.

Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration.

A Rare Finding at the Hepaticojejunostomy in a Postliver Transplant Patient.

Primary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges.

Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study.

A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitis.

Advanced therapies for inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and meta-analysis.

Primary sclerosing cholangitis in children: a single-center experience and evaluation of prognostic markers.

Liver Transplant in Primary Sclerosing Cholangitis: Results in Our Center.

Association between type 2 diabetes and autoimmune liver disease: An integrated analysis of Mendelian randomization and clinical samples.

Superior Diagnostic Performance of 99mTc-FAPI-46 SPECT/CT Versus 18FDG PET/CT in Detecting Peritoneal Involvement in Mucinous Adenocarcinoma of the Colon.

Clinical Outcomes in Patients with Primary Sclerosing Cholangitis With and Without Inflammatory Bowel Disease.

Decoding the Role of H19 in Cholestatic Liver Injury Using snRNA-seq, Spatial Transcriptomics, and Machine Learning-Based Disease Prediction.

Current and Emerging Approaches for Management of Primary Sclerosing Cholangitis.

Ileal Bile Acid Transporter Inhibitors in Cholestasis: Potential for More Than Just Paediatrics?

Association between osteoporosis and waitlist mortality in liver transplant candidates.

Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel disease cohort.

Autoimmune hepatitis overlap syndrome: Clinical presentation, treatment response, and disease evolution: Tertiary centre experience.

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre Study.

Long-term clinical and endoscopic outcomes of ulcerative colitis after liver transplantation: a multicenter cohort study on the use and safety of advanced therapies.

Prevalence and Risk Factors of Colorectal Cancer in Solid Organ Transplant Recipients: A Systematic Review and Meta Analysis.

Multimodal treatment and tumour biology-driven long-term survival in PSC-associated hilar cholangiocarcinoma: A case report.

Vedolizumab induced acute interstitial nephritis.

MUC1 as a biomarker in primary sclerosing cholangitis and cholangiocarcinoma.

Serum anti-integrin αvβ6 autoantibodies for diagnosis of primary sclerosing cholangitis: a systematic review and meta-analysis.

Management of Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis Pre- and Post-liver Transplantation.

Bile acids as therapeutic agents.

Elevated Epithelial Splicing Regulatory Protein 1 Expression in Biliary Atresia Indicates Its Potential as a Molecular Marker.

Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol.

[Immunopathogenesis and therapy of primary sclerosing cholangitis].

HERACLIS-PSC: Current characteristics of primary sclerosing cholangitis with or without inflammatory bowel disease in Greece-a national multicenter cohort study.

Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine.

Updated Systematic Review and Meta-Analysis of Duct-to-duct Versus Hepaticojejunostomy Reconstruction After Liver Transplantation for Primary Sclerosing Cholangitis.

Cholestatic biomarkers and symptoms in primary sclerosing cholangitis: a post-hoc analysis of the DILSTENT.

Dietary Lauric Acid Suppresses Inflammation, Cholestasis, Hepatocyte Injury, and Senescence in 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-induced Inflammatory Cholangiopathy.

Eosinophilic cholangitis without peripheral eosinophilia presenting as a localized bile duct stricture mimicking perihilar cholangiocarcinoma.

Decoding follicular cholangitis: A benign entity with a malignant façade.

Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan.

Fecal calprotectin in patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.

FIRST BRAZILIAN CONSENSUS ON CHOLANGIOPANCREATOSCOPY BY THE BRAZILIAN SOCIETY OF DIGESTIVE ENDOSCOPY (SOBED).

A multilevel analysis of the genetic association between inflammatory bowel disease and primary sclerosing cholangitis.

The Scope of Percutaneous Biliary Cholangioscopy: Beyond Choledocholithiasis.

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

MAIT Cells in Liver Disease.

DNA Methylation-mediated BTN3A2 Regulation via CD14+CD16+ Monocytes Protects Against Primary Sclerosing Cholangitis.

Multicenter Validation Study of the Clinical Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis 2020 in Japan.

[On familiar terms with the bile and pancreatic ducts : Where is the benefit?].

Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis.

Validation of Quantitative Magnetic Resonance Cholangiopancreatography Metrics in Prediction of Transplant-free Survival in Primary Sclerosing Cholangitis.

The Prognostic Utility of Quantitative Magnetic Resonance Cholangiopancreatography in Patients With PSC: A Systematic Review With Structured Evidence Synthesis.

Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.

Protocol for fabricating a vascularized bile duct-on-a-chip.

Clinical, Endoscopic, and Upper Gastrointestinal Histological Manifestations in Pediatric Inflammatory Bowel Disease: Insights from a Large Cohort.

Quality and Quantity? The Clinical Significance of Myosteatosis in Various Liver Diseases: A Narrative Review.

Graves' disease with autoimmune hepatitis and primary Sclerosing cholangitis: an overlap syndrome.

Single-Cell Genetic Mapping of Gasdermin Expression Across Immune-Mediated Inflammatory Diseases.

Hepatocyte Mettl3 Deficiency Drives Primary Sclerosing Cholangitis and Liver Fibrosis via Cholangiocyte-Macrophage Crosstalk.

Novel MicroRNA biomarkers revealed in the serum and bile of thioacetamide induced cholangiocarcinoma.

Exploring the biliary microbiome in hepatopancreatobiliary disorders: a comprehensive systematic review of microbial signatures and diagnostic potential.

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

Mechanistic roles and therapeutic potential of bacteriophages in inflammatory gastrointestinal diseases.

Ubiquitin D Correlates with Disease Severity and T Cell Infiltration in Cholestasis: Evidence from Integrated Bioinformatics and Experimental Analyses.

Endoscopic retrograde cholangiopancreatography and primary sclerosing cholangitis: a retrospective study of a high-volume program.

Viral infection as a trigger for primary sclerosing cholangitis in genetically susceptible individuals.

Burden of primary sclerosing cholangitis in Sweden (2002-2020): Incidence, outcomes, healthcare utilization, and costs.

A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms.

Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.

Biliary Reconstruction in Liver Transplantation with Primary Sclerosing Cholangitis: Roux-en-Y Hepaticojejunostomy or Duct-to-Duct Anastomosis?

From Isolation to Information: Launching an Online Community for Patients with Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis in Romania-A Descriptive Study.

Risk of Incident Immune-Mediated Inflammatory Diseases with Second Tumor Necrosis Factor Inhibitor Versus Alternative Biologic Therapy in Patients with Inflammatory Bowel Disease and First TNFi Exposure: A Real-World Cohort Study.

Radial laser ablation under cholangioscopic guidance for a tight intrahepatic bile duct stricture caused by primary sclerosing cholangitis.

Pembrolizumab-Induced Secondary Cholangitis: A Case Report.

Beyond futility: The history and potential of liver transplantation in cholangiocarcinoma.

Risk factors for autoimmune liver disease recurrence after liver transplantation.

Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH.

miR-21-5p dysregulation is associated with gut microbiota dysbiosis and pro-oncogenic markers in primary sclerosing cholangitis with concomitant inflammatory bowel disease.

Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity: a multicentre, prospective observational study.

Risk of intestinal complications, extraintestinal morbidity, and mortality in patients with ulcerative colitis and ocular involvement.

Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study Across Asia.

Risk of Intestinal and Extraintestinal Malignancies in Inflammatory Bowel Disease With and Without Primary Sclerosing Cholangitis.

Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025.

A retrospective evaluation of preemptive liver transplantation for bile duct dysplasia in primary sclerosing cholangitis: Balancing risks and benefits.

Intestinal barrier in chronic gut and liver diseases: Pathogenesis and therapeutic targets.

Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Fatigue and Pruritus in Primary Sclerosing Cholangitis: A U.S. Single-Center Study.

Blood and tissue dysregulated bile acids and short-chain fatty acids in cholangiocarcinoma.

Differences in Anti-αvβ6 Integrin Antibody Expression between U.S. and Japanese Cohorts in Inflammatory Bowel Disease.

Systemic PCSK9 elevation characterises autoimmune liver disease across sexes.

An overview of paediatric autoimmune and genetic cholestatic liver disease for the adult physician.

Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant response.

Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case Series.

Causal associations between primary sclerosing cholangitis and systemic lupus erythematosus: Evidence from Mendelian randomization and transcriptomic analyses.

Hepatobiliary and pancreatic findings on magnetic resonance enterography examinations in children with newly diagnosed inflammatory bowel disease.

Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study.

Selective Inhibitors of Toll-Like Receptor 9 (TLR9) Could Potentially Treat Fibrotic, Autoimmune, and Inflammatory Diseases.

Lipoprotein X-Induced Hyperlipidemia Following Liver Transplantation in the Setting of Persistent Cholestasis and Antibody-Mediated Rejection.

Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers.

Causal mediation of immune cells in autoimmune liver diseases and oral cancer risk: a mendelian randomization study.

Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis.

Numb-exon3 and full length Numb equivalently alleviate cholestatic liver fibrosis by inhibiting ductular reaction.

Risk stratification of IBD-associated liver disease using routinely collected biomarkers from a large-scale real-world dataset.

Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP.

Gut-Liver Axis, Microbiota, Bile Acids, and Immune Response in Pathogenesis of Primary Sclerosing Cholangitis: An Overview.

Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.

Primary sclerosing cholangitis: a narrative review of diagnostic and prognostic biomarkers.

Chronic Recurrent Multifocal Osteomyelitis Associated in a Child with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Case Report.

Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study.

Phase II clinical trials in primary sclerosing cholangitis: Making the most of every opportunity?

Genetic architecture of primary sclerosing cholangitis: shared pathways with inflammatory bowel disease and gut-liver axis mediation.

Microbiome and gut-liver interactions: From mechanisms to therapies.

Dietary and Lifestyle Risk Factors in Primary Sclerosing Cholangitis: In Search of Mechanistic Explanations and Health Improvement.

Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial.

Liver transplantations in Finland over 40 years: evolution and recent trends.

Quantitative MRCP as Part of Primary Sclerosing Cholangitis Standard of Care in the National Health Service in England: A Feasibility Assessment Among Hepatologists.

Macrophages in Autoimmune Liver Diseases: From Immune Homeostasis to Precision-Targeted Therapy.

Infections in primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.

Apremilast as a novel therapeutic option for psoriasis coexisting primary sclerosing cholangitis and ulcerative colitis: A case report.

Primary Sclerosing Cholangitis in a Child: A Rare Case Report.

Association of Primary Sclerosing Cholangitis With HLA-C*07:02 in a Japanese Population.

Navigating the Hepatic Immune Landscape With Fine Needle Aspiration of the Liver-An Emerging Technique.

Cultured bacteria isolated from primary sclerosing cholangitis patient bile induce inflammation and cell death.

Ulcerative colitis and colorectal cancer: Pathogenic insights and precision strategies for prevention and treatment.

Innate immune cell LXR-β deficiency exacerbates hepatic injury and fibrosis in murine models of primary sclerosing cholangitis.

Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus.

Cholangiocarcinoma - Morphology, Immunohistochemistry, and Genetics.

Spatial heterogeneity in liver stiffness does not predict clinical outcomes in patients with primary sclerosing cholangitis.

Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study.

Point-of-Care Testing and Biomarkers in Biliary Diseases: Current Evidence and Future Directions.

Localization of the therapeutic targets for endothelin receptor antagonists and sodium-glucose co-transporter 2 inhibitors in the chronic liver disease, primary sclerosing cholangitis.

Autoimmune Hepatitis Associated with Other Autoimmune Diseases: A Critical Review.

Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk.

EGFR activation in cholangiocytes promotes extrahepatic bile duct regeneration after injury.

Disruption of Bile Acid Metabolism in the Gut-Liver Axis Predisposes Mice to Inflammatory Bowel Disease.

Large duct primary sclerosing cholangitis with or without inflammatory bowel disease in Saudi patients.

Relationship between depression and chronic liver disease: Potential role of antidepressants in modulating liver fibrosis.

From inflammation to carcinogenesis: Distinct pathways and clinical implications of IBD-associated colorectal cancer compared with sporadic CRC.

Identification of MMEL1 as a novel therapeutic target for primary sclerosing cholangitis: Integrating Mendelian randomization and transcriptome landscapes.

Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases.

Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis.

Radiomics-Based Prognostication in Primary Sclerosing Cholangitis: A Proof-of-Concept Study.

Microbial Landscapes of the Gut-Biliary Axis: Implications for Benign and Malignant Biliary Tract Diseases.

Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies.

Antineutrophil Cytoplasmic Autoantibodies Specific to Bactericidal/Permeability-Increasing Protein: A Cross-Road Between Prolonged Gram-Negative Bacterial Infections and Ulcerative Colitis/Primary Sclerosing Cholangitis.

Long-Term Clinical and Endoscopic Outcomes of Crohn's Disease Following Liver Transplantation: A Multicenter Cohort Study.

Clinical and Prognostic Factors Associated With Inflammatory Bowel Disease in a Highly Admixed Population With Primary Sclerosing Cholangitis.

Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies.

Organoids in biliary research: insights into developmental signaling and applications in disease modeling.

68Ga-FAPI-46 PET/CT in Primary Sclerosing Cholangitis and Suspected Cholangiocarcinoma.

Human T-Lymphotropic Virus Type 1-Associated Myelopathy With Autoimmune Cholangiopathy: An Unusual Immune Conundrum in a Young Patient.

Chance of pouch surgery after colectomy for ulcerative colitis based on pelvic pouch volumes at the colectomy hospital, a Swedish national cohort study.

The regulatory roles of pparα on hepatic drug-metabolizing enzymes in primary sclerosing cholangitis Syrian hamsters.

Advances in Construction and Application of Biliary Organoids.

Chronic abdominal pain secondary to portosystemic collateral vessels: A case report and review of etiologies.

Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment.

Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC Cohort.

Development and Validation of a Scaffold-Free Human Multilineage Spheroid Model for Early Stage Cholangiopathies Driven by Cholangiocyte Senescence.

Sarcopenia-A Valuable Imaging Biomarker for Disease Progression in Patients With Primary Sclerosing Cholangitis (PSC)?

Causal relationship of body mass index with autoimmune liver diseases mediated by circulating cytokines: A Mendelian randomization study.

Revealing the enigmatic interplay between helicobacter pylori infection and biliary system diseases using Mendelian randomization analysis.

Primary Sclerosing Cholangitis Worsens Prognosis in Patients With Inflammatory Bowel Disease: A Propensity-Matched Cohort Study.